# PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

> **NCT00928408** · — · COMPLETED · sponsor: **Amgen** · enrollment: 305 (actual)

## Conditions studied

- Hyperparathyroidism, Primary

## Interventions

- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT00928408
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928408, "PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00928408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*